PDPN and neoplasm: Mice harboring PDPN+CD133+ tumors had a median survival of 99 (n=5) days, while mice that received PDPN-CD133+ cells did not succumb to tumor formation (n=3) (p=0.0136, log-rank test; Figure 2C).